The mobile platform allows clinicians in primary care and at-home care to capture retinal images to screen for several eye diseases in minutes. Diseases the platform can screen for include diabetic retinopathy, glaucoma and age-related macular degeneration.
Spect said it will use the funds to further develop the platform’s AI capabilities, grow its team and expand diagnostic access and partnerships within the healthcare industry.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
